Mitogenic activity toward human breast cancer cell line MCF-7 of two bFGFs purified from sera of breast cancer patients: Co-operative role of cathepsin D

Breast Cancer Research and Treatment

Volumn 43, Issue 1, 1997, Pages 53-63

  Takei, Yoshifumi ^a   Higashira, Hanae ^a   Yamamoto, Toshiya ^a   Hayashi, Kyozo ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Basic fibroblast growth factor (bFGF); Breast cancer; Cathepsin D; MCF 7; Mitogenic activity

Indexed keywords

ASPARTIC PROTEINASE; BASIC FIBROBLAST GROWTH FACTOR; CATHEPSIN D;

AFFINITY CHROMATOGRAPHY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CULTURE MEDIUM; DEGRADATION; ENZYME IMMUNOASSAY; GEL FILTRATION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MITOGENESIS; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANTIBODIES; BREAST NEOPLASMS; CATHEPSIN D; CELL DIVISION; CULTURE MEDIA, CONDITIONED; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MOLECULAR WEIGHT; TUMOR CELLS, CULTURED;

EID: 0031051699     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005749925296     Document Type: Article

References (30)

1. Heldin CH, Johnson A, Wennergren S, Wernstedt C, Westermark B: A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A chain. Nature 319:511-514, 1986
2. Sporn MB, Robert AB: Autocrine growth factors and cancer. Nature 313: 745-747, 1985
3. Lam LC, Delikantny EJ, Orr FW, Wass J, Varani J, Ward PA: The chemotactic response of tumor cells: A model for cancer metastasis. Am J Pathol 104: 69-76, 1981
4. Bacilico C, Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 59: 115-165, 1992
5. Smith JA, Winslow DP, Rudland PS: Different growth factors stimulate cell division of rat mammary epithelial, myocpithelial and stromal cell lines in culture. J Cell Physiol 119: 320-326, 1984
6. Karey KP, Sirbasku DA: A differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol. Cancer Res 48: 4083-4092, 1988
7. Takahashi K, Suzuki K, Kawahara S, Ono T: Growth stimulation of human breast epithelial cells by basic fibroblast growth factor. Int J Cancer 43: 870-874, 1989
8. Riss TL, Sirbasku DA: Characterization of polyclonal antibodies that distinguish acidic and basic fibroblast growth factors by using Western immunoblotting and enzyme-linked immunosorbent assays. J Cell Physiol 138: 405-414, 1989
9. Kurobe M, Takei Y, Ezawa H, Hayashi K: Increased level of basic fibroblast growth factor (bFGF) in sera of patients with malignant tumors. Horm Metab Res 25: 395-396, 1993
10. + conjugates: Application for two-site enzyme immunoassay and immunohistochemical detection. Bioconjugate Chemistry 4: 134-138, 1993
11. Takei Y, Kurobe M, Uchida A, Hayashi K: Serum concentration of basic fibroblast growth factor in breast cancer. Clin Chem 40: 1980-1981, 1994
12. Takei Y, Kurobe M, Uchida A, Hayashi K: Presence of high-molecular-weight basic fibroblast growth factor-like immunoreactive substance in sera of patients with breast cancer. J Clin Biochem Nutr 15: 57-64, 1993
13. Takei Y, Higashira H, Hayashi K: Partial purification of immunoreactive basic fibroblast growth factors from sera of patients with breast cancer and investigation of their mitogenic activity toward BALB/c3T3 fibroblasls. J Clin Biochem Nutr 17: 19-28, 1994
14. Seno M, Iwane M, Sasada R, Moriya N, Kurokawa T, Igarashi K: Monoclonal antibodies against basic fibroblast growth factor. Hybridoma 8: 209-221, 1989
15. Iwane M, Kurokawa T, Sasada R, Seno M, Nakagawa S, Igarashi K: Expression of cDNA encoding human basic fibroblast growth factor in E. coli. Biochem Biophys Res Commun 146:470-477, 1987
16. Takei Y, Higashira H, Hayashi K: Improvement of an enzyme immunoassay system for basic fibroblast growth factor by use of biotinylated antibody prepared with NHS-LC-Biotin. J Clin Lab Anal 9: 96-100, 1995
17. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68, 1980
18. Capony F, Rougeot C, Montcourrier P, Cavailles V, Salazar G, Rochefort H: Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res 49: 3904-3909, 1989
19. Vignon F, Capony F, Chamhon M, Freiss G, Garcia M, Rochefort H: Autocrine growth stimulation of the MCF-7 breast cancer cells by the estrogen-regulated 52K protein. Endocrinology 118: 1537-1545, 1986
20. Briozzo P, Morisset M, Capony F, Rougeot C, Rochefort H: In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res 48: 3688-3692, 1988
21. Lehtola L, Partanen J, Sistonen L, Korhonen J, Warn A, Harkhonen P, Clarke R, Alitalo K: Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells. Int J Cancer 50: 598-603, 1992
22. Briozzo P, Badet J, Capony F, Pieri I, Montcourrier P, Barritault D, Rochefort H: MCF-7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: A permissive role of cathepsin D. Exp Cell Res 194: 252-259, 1991
23. Conover CA, Perry JE, Tindall DJ: Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. J Clin Endocrinol Metab 80: 987-993, 1995
24. Baron R, Neff L, Louvard D, Courtoy PJ: Cell-mediated extracellular acidification and bone resorption: evidence for a low PH in resorbing lacunae and localization of a 100 Kd lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 101: 2210-2222, 1985
25. Van Beek WP, Smets LA, Emmelot P: Increased sialic acid density in surface glycoprotein of transformed and malignant cells. A general phenomenon? Cancer Res 33: 2913-2922, 1973
26. Spechler SJ, Esposito AL, Koff RS: Lactic acidosis in oat cell carcinoma with extensive hepatic metastases. Arch Inter Med 138: 1663-1664, 1978
27. Hanneken A, Ying W, Ling N, Baird A: Identification of soluble forms of the FGF receptor in blood. Proc Natl Acad Sci USA 91: 9170-9174, 1994
28. Baird A, Schubert D, Ling N, Guillemin R: Receptor- and heparin-binding domains of basic fibroblast growth factor. Proc Natl Acad Sci USA 85: 2324-2328, 1988
29. Simon DI, Xu H, Vaughan DE: Cathepsin D-like aspartyl protease activity mediates the degradation of tissue-type plasminogen activator/plasminogen activator inhibitor-1 complexes in human monocytes. Biochim Biophys Acta 1268: 143-151, 1995
30. Jarosz DE, Hamer PJ, Tenney DY, Zabrecky JR: Elevated levels of pro-cathepsin D in the plasma of breast cancer patients. Int J Oncol 6: 859-865, 1995